These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 36843721)
1. Evaluating Adherence to Diabetic Retinopathy Care in an Urban Ophthalmology Clinic Utilizing the Compliance With Annual Diabetic Eye Exams Survey. Davis TS; Luo F; Xie SJ; Muro-Fuentes EA; Rodrigues EB Cureus; 2023 Jan; 15(1):e34083. PubMed ID: 36843721 [TBL] [Abstract][Full Text] [Related]
2. Predicting adherence to diabetic eye examinations: development of the compliance withAnnual Diabetic Eye Exams Survey. Sheppler CR; Lambert WE; Gardiner SK; Becker TM; Mansberger SL Ophthalmology; 2014 Jun; 121(6):1212-9. PubMed ID: 24518614 [TBL] [Abstract][Full Text] [Related]
3. Patients' Adherence to Recommended Follow-up Eye Care After Diabetic Retinopathy Screening in a Publicly Funded County Clinic and Factors Associated With Follow-up Eye Care Use. Keenum Z; McGwin G; Witherspoon CD; Haller JA; Clark ME; Owsley C JAMA Ophthalmol; 2016 Nov; 134(11):1221-1228. PubMed ID: 27632231 [TBL] [Abstract][Full Text] [Related]
4. Psychometric assessment and application of the Chinese version of the Compliance with Annual Diabetic Eye Exams Survey in people with diabetic retinopathy. Zhu X; Xu Y; Xu X; Zhu J; He X; Lu L; Zou H Diabet Med; 2020 Jan; 37(1):84-94. PubMed ID: 31365948 [TBL] [Abstract][Full Text] [Related]
5. Patient Perceptions of SARS-CoV-2 Exposure Risk and Association With Continuity of Ophthalmic Care. Lindeke-Myers A; Zhao PYC; Meyer BI; Liu EA; Levine DA; Bennett OM; Ji S; Newman-Casey PA; Rao RC; Jain N JAMA Ophthalmol; 2021 May; 139(5):508-515. PubMed ID: 33704358 [TBL] [Abstract][Full Text] [Related]
6. Characteristics Associated with Adherence to Annual Dilated Eye Examinations among US Patients with Diagnosed Diabetes. Eppley SE; Mansberger SL; Ramanathan S; Lowry EA Ophthalmology; 2019 Nov; 126(11):1492-1499. PubMed ID: 31281055 [TBL] [Abstract][Full Text] [Related]
7. Anti-Vascular Endothelial Growth Factor and Panretinal Photocoagulation Use after Protocol S for Proliferative Diabetic Retinopathy. Azad AD; Chen EM; Hinkle J; Rayess N; Wu D; Eliott D; Mruthyunjaya P; Parikh R Ophthalmol Retina; 2021 Feb; 5(2):151-159. PubMed ID: 32693033 [TBL] [Abstract][Full Text] [Related]
8. Improving eye care follow-up adherence in diabetic patients with ocular abnormalities: the effectiveness of patient contracts in a free, pharmacy-based eye screening. Aleo CL; Murchison AP; Dai Y; Hark LA; Mayro EL; Collymore B; Haller JA Public Health; 2015 Jul; 129(7):996-9. PubMed ID: 26119987 [TBL] [Abstract][Full Text] [Related]
9. Barriers to Follow-Up and Strategies to Improve Adherence to Appointments for Care of Chronic Eye Diseases. Thompson AC; Thompson MO; Young DL; Lin RC; Sanislo SR; Moshfeghi DM; Singh K Invest Ophthalmol Vis Sci; 2015 Jul; 56(8):4324-31. PubMed ID: 26176869 [TBL] [Abstract][Full Text] [Related]
10. Pan-retinal photocoagulation and other forms of laser treatment and drug therapies for non-proliferative diabetic retinopathy: systematic review and economic evaluation. Royle P; Mistry H; Auguste P; Shyangdan D; Freeman K; Lois N; Waugh N Health Technol Assess; 2015 Jul; 19(51):v-xxviii, 1-247. PubMed ID: 26173799 [TBL] [Abstract][Full Text] [Related]
11. Effectiveness of Panretinal Photocoagulation Plus Intravitreal Anti-VEGF Treatment Against PRP Alone for Diabetic Retinopathy: A Systematic Review With Meta-Analysis. Zhang W; Geng J; Sang A Front Endocrinol (Lausanne); 2022; 13():807687. PubMed ID: 35422768 [TBL] [Abstract][Full Text] [Related]
12. Factors associated with pediatric ophthalmology follow-up adherence before and during the COVID-19 pandemic. Hekmatjah N; Turner CH; Mesfin Y; Zhang L; Han Y; O'Brien KS; Oatts JT J AAPOS; 2024 Aug; 28(4):103963. PubMed ID: 38955242 [TBL] [Abstract][Full Text] [Related]
13. Racial/Ethnic Disparities and Barriers to Diabetic Retinopathy Screening in Youths. Thomas CG; Channa R; Prichett L; Liu TYA; Abramoff MD; Wolf RM JAMA Ophthalmol; 2021 Jul; 139(7):791-795. PubMed ID: 34042939 [TBL] [Abstract][Full Text] [Related]
14. Social determinants of health impacting adherence to diabetic retinopathy examinations. Cai CX; Li Y; Zeger SL; McCarthy ML BMJ Open Diabetes Res Care; 2021 Sep; 9(1):. PubMed ID: 34583972 [TBL] [Abstract][Full Text] [Related]
15. Factors Affecting Compliance with Diabetic Retinopathy Screening: A Qualitative Study Comparing English and Spanish Speakers. Hudson SM; Modjtahedi BS; Altman D; Jimenez JJ; Luong TQ; Fong DS Clin Ophthalmol; 2022; 16():1009-1018. PubMed ID: 35400992 [TBL] [Abstract][Full Text] [Related]
16. Adherence to ophthalmology referral, treatment and follow-up after diabetic retinopathy screening in the primary care setting. Bresnick G; Cuadros JA; Khan M; Fleischmann S; Wolff G; Limon A; Chang J; Jiang L; Cuadros P; Pedersen ER BMJ Open Diabetes Res Care; 2020 Jun; 8(1):. PubMed ID: 32576560 [TBL] [Abstract][Full Text] [Related]
17. Factors Associated with Follow-Up Adherence After Teleophthalmology for Diabetic Eye Screening Before and During the COVID-19 Pandemic. Luo S; Lock LJ; Xing B; Wingelaar M; Channa R; Liu Y Telemed J E Health; 2023 Aug; 29(8):1171-1178. PubMed ID: 36576981 [No Abstract] [Full Text] [Related]
18. Behavioral economics and diabetic eye exams. Williams AM; Liu PJ; Muir KW; Waxman EL Prev Med; 2018 Jul; 112():76-87. PubMed ID: 29626555 [TBL] [Abstract][Full Text] [Related]
19. Intravitreal anti-vascular endothelial growth factors, panretinal photocoagulation and combined treatment for proliferative diabetic retinopathy: a systematic review and network meta-analysis. Fallico M; Maugeri A; Lotery A; Longo A; Bonfiglio V; Russo A; Avitabile T; Pulvirenti A; Furino C; Cennamo G; Barchitta M; Agodi A; Reibaldi M Acta Ophthalmol; 2021 Sep; 99(6):e795-e805. PubMed ID: 33326183 [TBL] [Abstract][Full Text] [Related]